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Spongiform degenerationIn clinical practice signal hyperintensity in the cortex and/or in the striatum on magnetic resonance (MR)
diffusion-weighted images (DWIs) is amarker of sporadic Creutzfeldt–Jakob Disease (sCJD). MR diagnostic accu-
racy is greater than 90%, but the biophysical mechanisms underpinning the signal abnormality are unknown. The
aim of this prospective study is to combine an advanced DWI protocol with newmathematical models of themi-
crostructural changes occurring in prion disease patients to investigate the cause of MR signal alterations. This
underpins the later development of more sensitive and speciﬁc image-based biomarkers. DWI data with a
wide a range of echo times and diffusion weightings were acquired in 15 patients with suspected diagnosis of
prion disease and in 4 healthy age-matched subjects. Clinical diagnosis of sCJDwasmade in nine patients, genetic
CJD in one, rapidly progressive encephalopathy in three, and Gerstmann–Sträussler–Scheinker syndrome in two.
Data were analysed with two bi-compartment models that represent different hypotheses about the histopath-
ological alterations responsible for theDWI signal hyperintensity. A ROI-based analysis was performed in 13 grey
matter areas located in affected and apparently unaffected regions from patients and healthy subjects. We pro-
vide for the ﬁrst time non-invasive estimate of the restricted compartment radius, designed to reﬂect vacuole
size, which is a key discriminator of sCJD subtypes. The estimated vacuole size in DWI hyperintense cortex was
in the range between 3 and 10 µm that is compatible with neuropathology measurements. In DWI hyperintense
grey matter of sCJD patients the two bi-compartment models outperform the classic mono-exponential ADC
model. Both new models show that T2 relaxation times signiﬁcantly increase, fast and slow diffusivities reduce,
and the fraction of the compartmentwith slow/restricted diffusion increases compared to unaffected greymatter
of patients and healthy subjects. Analysis of the rawDWI signal allows us to suggest the following acquisition pa-
rameters for optimized detection of CJD lesions: b = 3000 s/mm2 and TE= 103 ms. In conclusion, these results
provide the ﬁrst in vivo estimate of mean vacuole size, new insight on the mechanisms of DWI signal changes in
prionopathies and open the way to designing an optimized acquisition protocol to improve early clinical diagno-
sis and subtyping of sCJD.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/)., Bayesian information criterion;
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Prion diseases are transmissible, rapidly progressive and fatal neuro-
logical diseases. Despite their rarity and the lack of an effective treat-
ment, prion diseases draw exceptional scientiﬁc interest, mainly
because of their peculiar transmission mechanism, involving the pres-
ence of a misfolded isoform (PrPSc) of the cellular prion protein (PrPC)
and unique histological lesions. Sporadic Creutzfeldt–Jakob disease
(sCJD), the most common human prion disease, has a wide spectrum
of clinical and histopathological phenotypic heterogeneity that hasthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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features of sCJD have been described: astrocytosis, neuronal loss, intra-
cellular spongiform degeneration and PrPSc accumulation in extracellu-
lar space (Puoti et al., 2012). A great variability on lesion distribution,
spongiform degeneration and PrPSc accumulation is inﬂuenced by the
genotype at codon 129 and the PrPSc type (Gambetti et al., 2003). In par-
ticular, ﬁne spongiosis with small vacuoles is characteristic of the most
common phenotypes (MM1, MV1 and VV2), whereas coarse spongiosis
with large vacuoles is found in the MM2C and MV2C subtypes (Parchi
et al., 2012). For example, the vacuole average diameter in sCJDMM1
is 5.8± 1 µm, while in sCJDMM2, an sCJD subtypewhich can be difﬁcult
to distinguish clinically from sCJDMM1, the average vacuole diameter is
larger than 15 µm. The subtypes have quite different prognosis
(Gambetti et al., 2011), so a non-invasive technique for the estimation
of vacuole sizewould have a great importance. However, currently, def-
inite diagnosis of sCJD and its subtypes can bemade only by brain tissue
examination. Clinical criteria for the diagnosis of probable sCJD require
the presence of at least two clinical signs out of (i) dementia, (ii) cere-
bellar or visual, (iii) pyramidal or extrapyramidal, (iv) akinetic mutism,
and at least one of three tests 14-3-3 protein in CSF, periodic sharp-
wave complexes in the EEG, or abnormally high signal on Magnetic Res-
onance Imaging (MRI) must be positive (Zerr et al., 2009). In partic-
ular, asymmetric MRI hyperintensities on diffusion-weighted images
(DWIs) and T2-weighted Fluid Attenuated Inversion Recovery (FLAIR) in
at least three non-contiguous gyri or in the striatum or both are highly
suggestive for the diagnosis of sCJD. DWI is the best among standard
MRI sequences (Young et al., 2005; Kallenberg et al., 2006; Galanaud
et al., 2010; Vitali et al., 2011) with a diagnostic accuracy above 90%
(Shiga et al., 2004; Young et al., 2005; Satoh et al., 2007; Bizzi et al.,
2009; Galanaud et al., 2010; Vitali et al., 2011). However, even though
DWI hyperintensity is currently used as a marker of prion disease (Puoti
et al., 2012), the tissue alteration underlying this imaging signal remains
unknown. It has been reported that DWI sensitivity may vary among
prion diseases and sCJD subtypes (Krasnianski et al., 2006), which opens
the possibility to use it for early diagnosis of sCJD subtypes. Therefore,
the identiﬁcation of the histopathologic substrate associated with the
DWI signal abnormality is important, because it can guide the precise
choice of MRI protocol to maximize diagnostic power.
A few authors have looked for a correlation between neuropatholog-
ical changes and DWI hyperintensity or reduction in apparent diffusion
coefﬁcient (ADC). According to some groups (Geschwind et al., 2009;
Manners et al., 2009) DWI hyperintensities may be correlated with
spongiosis and PrPSc deposition rather than with gliosis and neuronal
loss; Lodi et al. (2009) found that patients with fatal insomnia, a prio-
nopathy associated with little or no spongiform changes (Parchi et al.,
1999), did not exhibit hyperintensities on DWI thus pointing to
spongiosis as the principal determinant of DWI signal hyperintensity.
On the other hand, Russmann et al. (2005) found no signiﬁcant correla-
tion between ADC and the degree of spongiosis, gliosis or neuronal loss.
The sensitivity of DWI to the random displacements of water mole-
cules in biological tissues makes it useful as a probe of tissue microstruc-
ture. Previous MRI studies of prion disease have focused (qualitatively or
semi-quantitatively) on the apparent hyperintensity on T2-weighted
FLAIR and DWI, or quantitatively on the ADC (Demaerel et al., 2003;
Tschampa et al., 2003; Lin et al., 2006; Galanaud et al., 2008; Hyare
et al., 2010a, b). Only a recent study (Caverzasi et al., 2014) performed a
slightlymore sophisticated analysis, by evaluating the fractional anisotro-
py (which did not show signiﬁcant differences between patients and
controls) and characterizing the evolution of ADCwith the pathology pro-
gression, which revealed a non-linear trend.
Signal in DWI depends on several parameters (Mori and Barker,
1999), including T2 relaxation (between 80 and 120 ms in healthy brain
tissue, but tends to increase with structural damage), the proton density
M0, and the water mobility within the tissue. The ADC factors out T2
and M0 providing a purer index of water mobility, but is still inﬂuenced
by awide range of factors. Recent trends in DWI, so-calledmicrostructureimaging, use mathematical models to relate DWI signals to histological
features; see for example Assaf et al. (2004), Barazany et al. (2009),
Panagiotaki et al. (2012), and Zhang et al. (2012). However, current tech-
niques largely consider healthywhitematter tissue, so are not directly ap-
plicable to explain the grey-matter DWI hyperintensity in prion disease.
In this prospective study we examine, for the ﬁrst time in consecutive
patientswith suspected prion disease, the potential ofmore sophisticated
mathematical models than the simple mono-exponential model used for
ADC estimation. We develop a modelling approach based on two main
hypotheses on the microstructural tissue alterations that may cause
DWI hyperintensity. Each hypothesis leads to a different family ofmathe-
matical models for how the DWI signal varies with echo time TE, b-value
and diffusion time. Our two hypotheses are: a) reduction of hindered dif-
fusivity caused by prion PrPSc deposition in the extracellular space; and
b) restriction of water diffusing within intracellular vacuoles. The key dif-
ference between the two hypotheses is that (b) implies restricted diffu-
sion, whereas (a) does not. In normal grey matter, a single or bi-
exponential model explains the DWI signal well (Clark and Le Bihan,
2000; Kiselev and Il3yasov, 2007). For hypothesis (a), we suppose that
PrPSc deposition hinders diffusion (i.e. slows down but does not trap
water molecules) in the extra-cellular space: the diffusivity is reduced
in the lesions but the displacement distribution is still Gaussian with a
variance linearly increasing with time. Thus we use a biexponential
model (Niendorf et al., 1996; Clark and Le Bihan, 2000; Mulkern et al.,
2001) to represent hypothesis (a). Under hypothesis (b), the conﬁnement
of water molecules inside the vacuoles leads to restricted diffusion that
has a non-Gaussian displacement distribution that depends on the
average size of the vacuoles. This condition is modelled with a two-
compartmentmodel,with restricted diffusion in a spherical compartment
(the vacuoles) and hindered diffusion in the other compartment, corre-
sponding to the extracellular space in the voxel. Eachmore provides esti-
mates of various parameters that contain more speciﬁc information than
the ADC. Both estimate compartmental diffusivities, as well as volume
fractions for each compartment. Moreover, model (b) provides estimates
of the average vacuole size, which offers potential as a non-invasive bio-
marker that discriminates prion disease subtypes. We also tested the
standard mono-exponential model (the ADC) for comparison with both
of the newly proposed models.
To test and compare the different mathematical models, we designed
an advanced acquisition scheme that explores the possible range of differ-
ent diffusion-weightings (b-values), diffusion times and T2-weightings as
widely as possible on a clinical 1.5 TeslaMR scanner. The schemeprovides
a uniquely broad sampling of the possible space of measurements with
which to evaluate the candidate models. The acquisition is not intended
as practical to run routinely for clinical assessment, but rather to provide
the best information with which to identify an appropriate model. Once
we have such a model, we can use it to ﬁnd an economical imaging
scheme that is practical for clinical assessment, for example using the ex-
periment design optimization algorithm described by Alexander (2008).
Overall, the study has two main aims: i) to evaluate the MR param-
eters of each model in healthy subjects and patients in order to see
which are informative about the presence of prion pathology and to un-
derstand if the proposedmodels can providemore information than the
ADC; and ii) to compare the models themselves in terms of ﬁtting per-
formance in order to see which hypothesis is more likely to explain the
signal changes. Thus, (i) leads to new clinical indices of prion pathology
and for a better characterization of speciﬁc features of the affected tis-
sue, while (ii) aims for a general understanding of the pathological
mechanism responsible for the signal hyperintensity.
2. Material and methods
2.1. Subjects
We recruited 15 consecutive patients with suspected diagnosis of
prion disease and four healthy age-matched elderly subjects. The
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their caregivers signed informed consent.
The diagnostic protocol included general clinical assessment, neuro-
logical evaluation, polygraphic EEG recording, analysis of the PRNP gene,
cerebral MRI and blood laboratory tests, CSF analysis for the presence of
14-3-3 and the levels of total tau protein was performed in 11 patients.
Diagnosis of “probable” sCJD was made according to the current diag-
nostic criteria (Zerr et al., 2009). Lack of brain tissue examination
impeded PrPSc type determination. However, one of six molecular sub-
types (MM1, MV1, MM2, MV2, VV1 and VV2) was tentatively assigned
to sCJD patients by three neurologists with expertise in prion disease
(V.R., P.G., F.T.) using available clinical data.
2.2. MR imaging acquisition
The study was performed on a 1.5 T MR imaging unit (Siemens
Avanto, Erlangen, Germany). The imaging protocol consisted of 264
DWIs and 26 interleaved b = 0 volumes, using a twice-refocused
(Reese et al., 2003) single shot spin-echo echo-planar imaging (SS-SE
EPI) sequence with four independent diffusion gradient directions,
a TR of 7.2 s, nine values of TE in the range of 68–107 ms and 13 b-
values in the range of 250–9000 s mm−2. For each TE, all the b-values
were used up to the maximum available for that TE, according to the
scheme in Inline Supplementary Table 1, and the four gradient direc-
tions were oriented in accordance to the tetrahedral symmetry, to
take advantage of the maximum physical gradient strength. 45 slices
were acquired,with a FOV of 220× 220mm2 and an isotropic resolution
of 2.3 × 2.3 × 2.3mm3. At each value of TE, the increasing b-values were
achieved by increasing the gradient strength with the timings of the
gradient pulses ﬁxed, and thus the intrinsic timescale of the measure-
ment. However, as TE increased, the lengths of the gradient pulses
increased, which provided measurements associated with longer diffu-
sion times. The twice-refocused single-shot spin-echo (SS-SE) sequence
has no single associated diffusion time, but measurements with longer
TE are sensitive broadly to dispersion over longer diffusion times. The
combination of measurements sensitive to different time scales and dif-
fusion weightings enables estimation of pore sizes (Clayden et al.,
2009). The range of pore diameters to which we have sensitivity, with
the gradient strength available on the Avanto system, is approximately
5–20 µm (Clayden et al., 2009; Dyrby et al., 2013), which is typical of
vacuole sizes in prionopathies (Kovacs and Budka, 2008).
Inline Supplementary Table S1 can be found online at http://dx.doi.
org/10.1016/j.nicl.2014.11.017.
Additionally, a clinical diffusion weighted SS-SE EPI sequence (TR=
3800 ms, TE = 74 ms, b-values 500 and 1000 s mm−2, 30 slices, FOV
230 × 230 mm2, in-plane resolution 1.8 × 1.8 mm2, slice thickness =
3.5 mm), a T2-weighted FLAIR (TE/TR/TI 121/8000/2500 ms, ﬂip angle
150°, 25 coronal slices, slice thickness 5 mm, in-plane resolution
0.78 × 0.78 mm2) and a volumetric T1-weighted magnetization-
prepared rapid acquisition gradient-echo sequence (MPRAGE, TE/TR/
TI 3.61/2400/1000 ms, ﬂip angle 8°, 160 sagittal slices, slice thickness
1.2 mm, in-plane resolution 1.25 × 1.25 mm2) were acquired. The
total acquisition time was about 45 min.
2.3. Imaging analysis
Images were corrected for head motion using FLIRT (FMRIB3s Linear
Image Registration Tool, University of Oxford, U.K., Jenkinson et al.,
2002). An afﬁne transformation with 12 degrees of freedomwas calcu-
lated to register each b0 volume to the ﬁrst one and then applied to
transform the subsequent DWIs into the same space.
Regions of interest (ROIs)weremanually drawn by an expert neuro-
radiologist in the following areas in the cortex and basal nuclei of each
subject: hippocampus (Hip), inferior temporal gyrus (ITG), superior
temporal gyrus (STG), caudate nucleus (Cau), anterior putamen
(aPut), dorso-medial thalamus (DMTh), occipital cortex (Occ), inferiorparietal lobule (IPL), superior parietal lobule (SPL), precuneus (PreCu),
anterior middle frontal gyrus (aMFG), superior frontal gyrus (SFG),
and anterior cingulate cortex (ACC). Each area was delineated in both
hemispheres and on multiple slices. In sCJD patients each ROI was clas-
siﬁed as affected or unaffected according to the presence or absence of
signal hyperintensity onDWI and if affected the delineationwas limited
to the area of evident hyperintensity. TheMR signal of each ROI was av-
eraged over all voxels and slices included by the ROI.
2.4. Models
The three models mentioned in the introduction were considered.
We started from a general form of each model and then simpliﬁed
them by adding some constraints on the parameters, as speciﬁed in
Appendix A. The ﬁnal forms are the following:
• The biexponential model is
S ¼ M0  e−
TE
T2 ½ f  e−b•d1 þ ð1− f Þe−bd2  ð1Þ
where the ﬁve free parameters are:M0, which is a steady-state magne-
tization parameter reﬂecting proton density; the T2 relaxation parame-
ter; d1 and d2, the apparent diffusivities in the two compartments; and f,
the volumetric fraction of the ﬁrst compartment.
We associate this model with hypothesis (a) in the introduction: re-
duced diffusivity due to PrPSc deposition. If PrPSc deposition only is re-
sponsible for DWI hyperintensity, we expect to ﬁnd a reduction of
diffusivity in at least one of the two compartments as the most signiﬁ-
cant difference between patients and controls. If we can associate the
two diffusivities with the intra and extracellular compartments, as
Clark and Le Bihan (2000) suggest, then we expect to see the reduction
in the extracellular compartment, which is normally that with the
higher diffusivity.
• The restricted diffusionmodel has two compartments, onewith re-
stricted diffusion in a spherical pore (the vacuole), and the other
with isotropically hindered diffusion. Mathematically, the model is:
S ¼ M0  e−
TE
T2 ½ f  Sphðb; TE; dR;RÞ þ ð1− f Þe−bdH  ð2Þ
where Sph(b,TE,dR,R) is the expression for the signal from water res-
tricted inside a sphere, which uses the Gaussian phase distribution ap-
proximation, as in Murday and Cotts (1968), but adapted for the twice-
refocused spin echo sequence as described in Clayden et al. (2009). The
Sph model has two free parameters: the radius R of the sphere and dR,
the intrinsic diffusivity inside the spherical compartment, whichwe ﬁxed
to the diffusivity of freewater at body temperature (3 × 10−9m2/s), since
vacuoles contain mostly water.
The other free parameters of this model are M0 and T2, as in the
biexponential model, the apparent diffusivity in the hindered compart-
ment, dH, and the volumetric fraction of the restricted compartment, f,
for a total of ﬁve free parameters.
We associate this model with hypothesis (b) in the introduction:
restriction in the vacuoles (the spherical compartment). If DWI hyper-
intensity is caused by restriction in the vacuoles, we expect to observe
an increase of f in the patients compared to the healthy subjects. Indeed
the volume fraction of the restricted compartment (the percentage of
the tissue occupied by restricting spheres) quantiﬁes the extent of iso-
tropic restriction, while the radius of the sphere reﬂects the size of the
restricting structures. If hypothesis (b) is true, these two parameters
should be markers of vacuolization and vacuolar size, respectively.
Table 1
Clinical data, MR imaging and laboratory test results for the 15 patients and 4 healthy controls.






Clinical ﬁndings PRNP mutation
Initial signs Full stage
Dementia Cerebellar /visual Pyramidal/ Extrapyr signs Behavioural disorder Mioclonus
CJD01 F 60 14 2 cognitive deﬁcits 1 1 0 1 1 E200K
CJD02 M 61 5 2 cognitive deﬁcits 1 1 0 0 0 0
CJD03 M 75 7 6 ataxia 1 1 1 0 0 0
CJD04 M 74 8 7 parkinsonism 1 0 1 1 1 0
CJD05 F 55 29 3 cognitive deﬁcits 1 0 0 1 0 0
CJD06 M 70 24 24 ataxia 1 1 1 0 1 0
CJD07 M 69 3 2 cognitive deﬁcits 1 1 1 1 1 0
CJD08 F 65 38 23 cognitive deﬁcits 1 0 1 1 0 0
CJD09 M 64 17 8 ataxia 1 1 0 0 0 0
CJD10 F 73 16 2 cognitive deﬁcits 1 0 1 0 1 0
GSS01 M 32 45 12 ataxia 0 1 0 0 0 P102L
GSS02 F 56 33 3 ataxia 0 1 0 0 0 P102L
RPE01 M 59 NA 10 cognitive deﬁcits 1 0 0 0 0 0
RPE02 F 80 8 5 ataxia 0 1 0 0 0 0
RPE03 M 81 NA 4 cognitive deﬁcits 1 0 0 1 0 0
HC01 F 66 - - - 0 0 0 0 0 -
HC02 M 59 - - - 0 0 0 0 0 -
HC03 M 59 - - - 0 0 0 0 0 -
HC04 M 63 - - - 0 0 0 0 0 -
The sCJD molecular subtype (MM1, MM2, MV1, MV2, VV2) was assigned to each patient according to the clinical data indicated in this table.
Abbreviations: CJD = Creutzfeldt-Jakob disease; GSS = Gerstmann–Sträussler–Scheinker syndrome; RPE = rapidly progressive encephalopathy; HC = healthy control; F = female; M =male; 1 = positive; 0 = negative; PRNP = PRioN Protein;










Patient code PRNP codon 129 14-3-3 Tau
(pg/ml)
DWI EEG Predicted sCJD
molecularsubtype
Average Radius in ROI
with signal hyperintensity
Average Radius in ROI without
signal abnormality
Clinical Diagnosis
CJD01 MV ND ND 1 0 - 5,54 0,2 familial CJD
CJD02 VV positive 15432 1 0 VV2 6,07 2,58 sCJD
CJD03 MV ambiguous 6983 1 1 MV2 4,13 1,84 sCJD
CJD04 MM ND ND 1 1 MM1 4,37 3,33 sCJD
CJD05 MM positive 2100 1 1 MM2 5,16 6,54 sCJD
CJD06 VV positive 2062 1 0 VV2 4,87 2,62 sCJD
CJD07 MV positive 2113 1 1 MV1 4,45 1,29 sCJD
CJD08 MV ambiguous 1648 1 0 MV2 7,32 8,02 sCJD
CJD09 MV positive 617 1 0 MV2 5,37 6,71 sCJD
CJD10 MV positive 2390 1 1 MV2 7,07 3,91 sCJD
GSS01 MM negative 462 0 0 - NA 1,85 GSS
GSS02 MM ND ND 0 0 - NA 2,53 GSS
RPE01 - negative 267 0 0 - NA 3,04 autoimmune encefalopathy
RPE02 - ambiguous 637 0 0 - NA 0,86 paraneoplastic encefalopathy
RPE03 - - - 0 0 - NA 2,53 paraneoplastic encefalopathy
HC01 - - - 0 - - NA NA Normal
HC02 - - - 0 - - NA NA Normal
HC03 - - - 0 - - NA NA Normal













with three free parameters:M0, T2 and ADC.
This is a simple standardmodel, whichwe include primarily to com-
pare our resultswith literature, and to understandwhat information the
more complex models can add.
2.5. Model ﬁtting
The three models described in Section 2.4 were ﬁtted to the mean
DWI signal in each ROI. We followed a ﬁtting procedure similar to that
in Panagiotaki et al. (2012); the details are reported in Appendix B.
2.6. Model comparison
The Bayesian Information Criterion (BIC, Schwarz, 1978)was used to
compare the performance of the different models (see Appendix B;
a worse ﬁtting performance results in a higher BIC value). All the
described procedures were implemented in MatLab (The Mathworks,
Natick, MA, USA).
2.7. Statistical analysis
For each anatomical area, the 38 ROIs (two ROIs per subject, in the
left and right hemispheres respectively) were divided in ﬁve groups:
CJD+ (i.e. affected ROIs in CJD patients), CJD− (i.e. unaffected ROIs in
CJD patients), HC (i.e. ROIs in healthy controls), RPE (i.e. ROIs in patients
with Rapidly Progressive Encephalopathy) and GSS (i.e. ROIs in patients
with Gerstmann–Sträussler–Scheinker syndrome); see Table 1 for the
diagnostic classiﬁcation of patients.
Since in the biexponential model the two terms in Eq. (2) have the
same expression, they are randomly associated with the “fast” compo-
nent (higher diffusivity) and the “slow” one (lower diffusivity) respec-
tively. After the ﬁtting procedure, we renamed the higher value
between d1 and d2 as dF and the lower one as dS in order to make
them more comparable between subjects. Accordingly, we redeﬁned f
as the fraction of the fast component.
Themean raw signal for each combination of acquisition parameters
was compared between CJD patients and controls, to understandwhich
combination is most sensitive to the anomalies.
The mean value and standard deviation of each estimated parameter
were calculated in each group, and a one-tailed t-test was used to test
the statistical signiﬁcance of differences between each of the pathological
groups and the healthy controls, both considering all the ROIs in each
group together and considering the different anatomical areas separately.
3. Results
3.1. Patients
Relevant clinical and laboratory data of the study population are re-
ported in Table 1. Of the 15 patients enrolled in the study with
suspected prion disease, nine were diagnosed as “probable” sCJD ac-
cording to the current criteria (Zerr et al., 2009), one as familial CJD as-
sociated with the E200K PRNPmutation, two as GSS linked to the P102L
PRNP mutation, and three as autoimmune encephalopathy. Cognitive
deﬁcits were the initial sign of disease in six patients with CJD and
twowith autoimmune encephalopathy,while ataxiawas thepresenting
symptom in three patients with CJD, one with autoimmune encepha-
lopathy and the two patients with GSS. One patient with CJD presented
with parkinsonism. DWI signal hyperintensity in the cerebral cortex
and/or striatum was observed in all CJD patients, while no signalabnormalities were detected in the individuals with GSS or autoim-
mune encephalopathy.
3.2. Raw MR signal intensity
A typical case of sCJD with signal hyperintensity in the cortical rib-
bon on DWI and FLAIR is illustrated on Fig. 1. The signal abnormality
is much more prominent on DWI with b = 1000 than with b = 500,
FLAIR and T2WI in this decreasing order. ADCmaps show decreased dif-
fusivity in the affected regions.
The mean raw signal in the CJD+ regions was higher than in CJD−
regions and in HC with all the considered combinations of b-value and
TE (Fig. 2A); this increase was consistent across all the parameter com-
binations and signiﬁcant in almost all of them. The signal in CJD− re-
gions was slightly higher than in controls, but the difference was
never signiﬁcant.
Since the human eye is sensitive to contrast rather than to absolute
signal, we calculated the relative difference of the raw signal between
each pair of groups (Fig. 2B). The contrast increased with b-value and
TE reaching a peakwith b=3000 s/mm2 and TE=103ms, then slightly
decreasing for even higher b-values. The estimated contrast-to-noise
ratio (CNR) at the peak was about 5.5, which was sufﬁciently high to
prove that the hyperintensity was not masked by noise.
3.3. Model ﬁtting performance
The quality of ﬁt was good for the biexponential and restricted-
diffusion models and the two models predict very similar signals,
while the mono-exponential model predicts quite different signals at
high b-values (see Fig. 3).
The BIC score was considered as a quantitative index of the ﬁtting
performance of the three models in each group of ROIs (Table 2). In
the affected ROIs (CJD+) the biexponential and restricted-diffusion
models performed signiﬁcantly better than the mono-exponential
model although they performed very similarly to one another (the dif-
ference was not signiﬁcant). Thus, although the ﬁtting results did not
show that either of the two hypotheses about the origin of the signal
hyperintensity was better than the other, they did show that both the
bi-compartment models provided a better ﬁt to the data than the stan-
dard mono-exponential model and so should provide more sensitive
and speciﬁc parameters. Also in the CJD− group and in controls we
found no signiﬁcant difference between the two bi-compartment
models and a signiﬁcant decrease of BIC in both of them compared to
the mono-exponential model, but this decrease was lower than in
CJD+.
We also observed that the BIC was always signiﬁcantly higher in
the affected regions than in the healthy ones; this suggests that
neither of our models fully explains the MRI signal in affected
areas, but the increased difference between the mono-exponential
and the bi-compartment models described above means that the
proposed models allow a considerably better characterization of
the pathological signal than the traditional one.
3.4. Differences in estimated MR parameters among groups
The results of the comparison among each patient group and healthy
controls are reported in Table 3; results for each anatomic region are re-
ported in Inline Supplementary Tables 2–6.
Inline Supplementary Table S2 can be found online at http://dx.doi.
org/10.1016/j.nicl.2014.11.017.
Inline Supplementary Table S3 can be found online at http://dx.doi.
org/10.1016/j.nicl.2014.11.017.
Inline Supplementary Table S4 can be found online at http://dx.doi.
org/10.1016/j.nicl.2014.11.017.
Inline Supplementary Table S5 can be found online at http://dx.doi.
org/10.1016/j.nicl.2014.11.017.
Fig. 1.MR images used for clinical diagnosis of sCJD in one patientwith sCJD acquired at the level of the basal nuclei and lateral ventricles. Affected (CJD+) regions look bright and aremore
prominent on DWI with b= 1000 than b= 500, FLAIR and T2WI respectively in this order. Affected regions with decreased diffusivity look darker on ADC maps. Note the asymmetry of
signal hyperintensities that in this patient are more extensive in the left cerebral hemisphere than in the right, basal nuclei and thalami.
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3.4.1. CJD + vs. healthy controls
In the affected regions of CJD patients (CJD+ group)we found an in-
crease of T2, a decrease of diffusivities and an increase of the fraction of
the restricted compartment with respect to controls (Table 3).
T2 was signiﬁcantly increased in CJD+ in almost all the areas and
in all three models (Fig. 4B). Lengthening in T2 relaxation time was
greatest in the frontal cortex, while it was lower in the parietal andFig. 2.Raw signal in the different groups. A) Raw signal in the threemain groups at each combin
pair of groups at each combination of the acquisition parameters.In both the plots, for any b-val
b-value in Inline Supplementary Table 1).temporal areas. Minor differences were observed when comparing the
different models.
The proton density, M0, was signiﬁcantly increased in the temporal
cortex and decreased in most of the other areas; some inconsistencies
were observed among the three models, thus this parameter was not
very informative.
Diffusivities were generally reduced in all three models. In the
biexponential model, dF was signiﬁcantly reduced in PreCu, SFG,
aMFG, SPL and aPut (Fig. 4C), while dS was reduced in PreCu, SFG,
aMFG, STG, SPL IPL and Occ (Fig. 4D); in most of the other areas dFation of the acquisition parameters. B) Relative difference between themean signal in each
ue reported on the graph, the TE grows from left to right (see the TE values applied at each
Fig. 3. Visual assessment of the quality of ﬁt in a representative ROI of a CJD patient. The raw signal (stars) and the signal predicted by each model (solid lines with different colours) are
shown for every volume acquired. See Supplementary Table 1 for the acquisition parameters applied.
Table 3
Results of the group analysis. Mean relative difference in each parameter between each
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diffusion model, the differences in dH were not signiﬁcant in most ana-
tomic regions. In themono-exponentialmodel, theADCwas signiﬁcant-
ly reduced in all the anatomical areas (Fig. 4E).
Differences in the fraction of the “fast” component of the biexpo-
nential model varied with the anatomical position: the fractionwas sig-
niﬁcantly increased in the frontal and parietal lobes and in PreCu,
signiﬁcantly decreased in Cau and DMTh.
The fraction of the spherical compartment in the restricted-diffusion
model was signiﬁcantly increased in all the areas but Hip (Fig. 4F). The
increase was particularly important (greater than 40%) in the temporal
and parietal cortex, PreCu and DMTh.
In all regions of the CJD+ group the mean radius of the spherical
compartment was in the range between 3 and 10 µm, compatible
with the dimensions of the vacuoles in CJD asmeasured by histopathol-
ogy (Kovacs and Budka, 2008), while in the control group the radii were
generally much smaller (about 1.6 µm on average). When averaged
across all the affected ROIs, the mean radius was larger (about 7 µm)
in 2 patients (CJD08 and CJD10) compared to the other 8 patients
(3–6 µm) (Fig. 5A). Differences in size were observed also among ana-
tomical areas: the radius was greater in SPL, PreCu, DMTh and Occ,
while it was smaller in frontal regions (aMFG, SFG, and ACC) (Fig. 5B).
The percentage of difference of each estimated parameter in each re-
gion is speciﬁed in Inline Supplementary Table 3.
3.4.2. CJD− vs. healthy controls
The relative alterations of T2 and of the fraction of the restricted com-
partment between the CJD− group and the control group (Table 3 and
Inline Supplementary Table 4) were generally smaller and less statisti-
cally signiﬁcant, but followed the trend of those reported above forTable 2
Mean BIC values for each model in CJD+, CJD− and HC ROIs.
BIC values CJD+ CJD− HC
Biexponential 2277 ± 141 (*,#) 2106 ± 156 (*) 2022 ± 80 (*)
Restricted 2287 ± 141 (*,#) 2116 ± 156 (*) 2031 ± 86 (*)
Mono-exponential 2633 ± 367 (#) 2305 ± 291 (#) 2143 ± 163
Higher values are associated with worse ﬁtting performances. Values marked with (*) are
signiﬁcantly lower than themean BIC of themono-exponential in the same group of ROIs,
showing a better ﬁtting performance of the bi-compartment models with respect to the
traditional one. Values marked with (#) are signiﬁcantly higher than the mean BIC of the
mono-exponential in the HC group, showing a worse ﬁtting performance with respect
to the normal case, probably due to pathological changes not fully explained by the
models.the CJD+ group. The radius of the spherical compartment in CJD−
was signiﬁcantly larger than in healthy and pathological controls
(p b 0.001) but smaller than in CJD+ regions (p b 0.001).
On the contrary in the CJD− group there was no signiﬁcant
change in diffusivity in the mono-exponential model (i.e. ADC), in the
biexponential model (i.e. dF and dS) nor in the restricted-diffusion
model (i.e. dH). This result suggests that the models tend to explain
the appearance of signal hyperintensity on DWI as a reduction of diffu-
sivity (biexponential model) or increase of intra-vacuolar volume frac-
tion (restricted model).3.4.3. RPE and GSS patients vs. healthy controls
In the RPE group we observed a slight increase of T2 and diffusivities
in comparison with healthy controls (Table 3 and Inline Supplementary
Table 5), while in the GSS group we found just few sporadic anatomic
reductions ofM0 and T2 (Inline Supplementary Table 6).3.4.4. CJD+ vs. RPE, GSS and controls
Wealso compared the CJD+groupwith the RPE andGSS groups and
with a “generalized” control group including all the ROIs in non-CJD
subjects (controls, RPE and GSS). In all three comparisons we found
similar results as between CJD+ and healthy controls. These results
demonstrated that increased T2, decreased diffusivities and increased
intracellular volume fraction are themain changes inMRparameters as-
sociated with regions of DWI signal hyperintensity.group (CJD+, CJD−, RPE or GSS respectively) and the healthy controls.
CJD+ CJD- RPE GSS
Biexponential M0 n.s. n.s. n.s. n.s.
T2 +26% +10% n.s. n.s.
dF -14% n.s. n.s. n.s.
dS -37% n.s. -20% n.s.
f +4% n.s. +9% n.s.
Restricted M0 n.s. n.s. n.s. n.s.
T2 +18% +8% n.s. n.s.
dH n.s. +8% +10% n.s.
f +46% +19% n.s. n.s.
Monoexp M0 -8% n.s. n.s. n.s.
T2 +31% +12% +5% n.s.
ADC -20% n.s. +5% n.s.
Abbreviations: n.s. = not signiﬁcant.
Fig. 4. Tridimensional representation of the regional dependence of statistical differences in
the estimated parameters. A) 3D rendering of the cortical and subcortical areas considered
in the ROI-based analysis. B–F) Representation of the statistical signiﬁcance of the differences
between CJD+andHC for themain parameters: T2 in themono-exponentialmodels (B) and
dF (C) and dS (D) in the biexponential model; ADC in the mono-exponential model (E); the
volumetric fraction of the spherical restricted compartment in the restricted-diffusion
model (F). In each panel the analysed areas without signiﬁcant differences are in blue,
while the areas with statistically signiﬁcant differences are in yellow (p b 0.05), orange
(p b 0.01) or red (p b 0.001).
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In this prospective study we have used mathematical models to an-
alyse differences in MR DWI signal acquired in patients with suspected
prion disease and controls. Data were acquiredwith an advanced imag-
ing protocol using many combinations of TE, diffusion weightings and
times that allowed an in-depth analysis of the MR signal abnormality.
For the ﬁrst timewe provided an estimate of the radius of the restricted
compartment that in affected ROIs may be related to the presence and
size of vacuoles. The estimated vacuole size in affected regions was in
the range between 3 and 10 µm that is compatible with the dimensions
of the vacuoles as measured by neuropathology in sCJD. In healthy sub-
jects and in non-CJD patient groups the restricted fraction was quite
small, that may suggest that there is no source of proper restriction.
The results of the model-based analysis showed signiﬁcantly longer T2,
lower diffusivity, or greater fraction of restricted diffusion in DWI hy-
perintense areas.
A ﬁrst analysis performed on raw MR signal showed a signiﬁcantly
higher signal in the CJD+ group with respect to healthy subjects, GSS
and RPE, across thewhole range of b-values. The absolute difference be-
tween the signal in CJD+ and controls in each ROI appears almost con-
stant across different echo times and b-values. The relative difference in
MR signal tends to increase with both b and TE, reaching a maximum at
b = 3000 s/mm2 and TE= 103 ms, which indicates an optimal operat-
ing point. Since the relative signal difference is closer to the contrast
seen by human eye than the absolute signal. Our results are in agree-
ment with previous studies (Hyare et al., 2010a; Riva-Amarante et al.,
2011) which suggested the use of high b-values (b = 3000) for better
contrast of CJD lesions.
In the second part of the study we analysed the MR signal intensity
with three mathematical models: biexponential, spherical restricted-
diffusion and mono-exponential. This is the ﬁrst study probing CJD
with diffusion models more complex than the mono-exponential one,
derived from two hypotheses about the origin of the hyperintensity
on DWI and FLAIR MR images in CJD patients. The aims of the model-
based analysis were (i) to evaluate the differences in the parameters
of each model associated with CJD, and (ii) to compare the models
themselves to understand the underlying neuropathological substrate.
As for aim (i), the statistical analysis highlighted some consistent differ-
ences: in CJD patients the T2 value is markedly increased in almost all
hyperintense affected regions, the diffusivities are generally reduced
in themono- and biexponentialmodels, and the fraction of the spherical
compartment estimated by the restricted-diffusion model is increased.
Although the ADC is the only parameter to show statistically signiﬁcant
differences in all the areas, this does not support themono-exponential
model. Thebiexponential and restricted-diffusionmodels also show sta-
tistically signiﬁcant differences in all the areas, but the particular MR
parameter explaining the difference changes: the models pin down the
source of the statistical differences more precisely to particular parame-
ters that are not the same in different anatomic regions.
The ADC numerical values found for CJD patients and controls in our
study are compatible with those reported by previous works that have
shown a reduction in ADC in CJD patients (Demaerel et al., 2003;
Tschampa et al., 2003; Hyare et al., 2010b). For the otherMR parameters
there are no previous numerical results in the literature, but our quan-
titative results are in agreement with qualitative results reported in
many clinical studies about the sensitivity of different MRI se-
quences to the detection of CJD. In particular, according to our re-
sults both the T2-weighted and the diffusion-weighted component
of the signal are altered; so FLAIR and T2-weighted sequences can
detect the pathology to some extent due to the alteration of T2,
but DWI sequences are much more sensitive because they include
both weightings (i.e. T2 and diffusion). The increase of the T2 relax-
ation time may be related to neuronal loss, resulting in a more ho-
mogeneous microenvironment due to reduction of microstructural
components that cause surface relaxation.
Fig. 5. Estimated radius of the spherical compartment in the different subjects and areas. A) Histogram showing the estimated radius averaged across all the ROIs in each subject.
B) Histogram showing the estimated radius averaged across all the CJD+ ROIs in each anatomical area.
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signiﬁcant increase in the radius of the spherical compartment was
found in sCJD patients compared with all controls, even though a direct
comparison is not very meaningful because the restricted fraction is
quite small in the controls where vacuoles are absent. A very small re-
stricted fraction may suggest that there is no source of restriction at
all; the relatively small mean diameter of the restricted compartment
suggests that the cause of restriction, if present, may be due to subcellu-
lar structures. The estimated radius of the spherical restricted compart-
ment in affected regions was in the range between 3 and 10 µm on
average, compatible with the dimension of the vacuoles in CJD as mea-
sured by histopathology (Kovacs and Budka, 2008). This supports the
association of the restricted portion of signal with the vacuoles, and
that the radius of the sphere is an estimation of the average size of the
vacuoles in the considered ROI or voxel. If conﬁrmed on a larger group
of patients with pathology-proven sCJD subtype, these results might
have implications for early in vivo diagnosis of sCJD subtype. We also
found interesting differences in average vacuolar size among anatomi-
cal areas; for example the estimated radius was smaller in the frontal
lobes, cingulate, hippocampus and caudate, and larger in the thalamus,
parietal and occipital lobes. This variation may reﬂect genuine differ-
ences in vacuole size, although other factors, such as differences in vac-
uole membrane permeability, may also inﬂuence the estimate.
Interestingly, in the “unaffected regions” of CJD patients (CJD−
group) we found an increase of T2 and of the fraction of the spherical
compartment in the restricted-diffusion model (although lower than
in affected CJD+ regions), but no coherent changes in diffusivities.
These results suggest that perhaps the pathological alterations in re-
gions without MR signal hyperintensity might be at subclinical stage.
Onlyminor differences inMRparameterswere found inGSS andRPE
patients with respect to healthy subjects; furthermore,we found almost
the same differences between the CJD+ group and each of the three
control groups (healthy, GSS and RPE). GSS is a genetic form of prion
disease characterized by accumulation of N- and C-terminal truncated
fragments of PrP in the form of amyloid plaques. Spongiform changes
are usually absent or mild, except for a subgroup of patients with the
P102L mutation showing a CJD-like phenotype. In patients with RPE
the absence of MR signal abnormalities was an early clue to eventually
rule out the diagnosis of sCJD. Thus we can conclude that the above re-
ported differences in T2, diffusivity and vacuolar volume fraction are
speciﬁc to CJD and unlikely related to unspeciﬁc neuronal degeneration.
With regards to the speciﬁc pathological mechanisms altering diffu-
sion properties, addressed in aim (ii), we observed that both the bi-
compartment models have a better ﬁtting performance than themono-exponential one, and the difference in BIC is much greater in
the affected ROIs than in the healthy tissue, even though the BIC values
themselves are higher. Small differences in BIC values for healthy sub-
jects show only small beneﬁts of the more complex models compared
to the mono-exponential, while in CJD+ the advantages of the more
complex models are much more signiﬁcant. Although our models can-
not capture all the signal abnormality (because the BIC is always higher
in CJD+ than in control ROIs) they represent a step towards a better
characterization of the affected tissue, and some interesting observa-
tions can be inferred by a detailed analysis of the results.
Since the biexponential and the restricted-diffusion models have
similar ﬁtting performances, a possible explanation is that both patho-
logical features of CJD may determine the MR signal abnormality to a
similar extent. In affected ROIs water diffusion might be both hindered
with lower diffusivity likely caused by prion PrPSc deposition in the
extracellular space (hypothesis a) and restricted in vacuoles with
impermeable barriers (hypothesis b). In the biexponential model the
reduction of diffusivity occurs in both extra and intracellular compart-
ments, which does not support hypothesis (a) directly, as this hypo-
thesis implies a reduction only in the extra-cellular “fast” diffusion
compartment. This observation does not refute hypothesis (a) because
the assignment of components in the biexponential model to the intra
and extracellular spaces is not strict (Clark and Le Bihan, 2000). Howev-
er, in the restricted-diffusion model the differences between CJD+ and
controls are found primarily in the restricted compartment and the dif-
fusivity in the hindered compartment is almost never signiﬁcantly al-
tered. This ﬁnding somewhat goes against the combined hypothesis.
Perhaps the biological mechanism involved in CJD is even more com-
plex thanwe initially anticipatedwith the two hypotheses. Permeability
of the vacuole walls is one possible mechanism that our models did not
consider. It would reduce observable restricted diffusion and produce
signal proﬁles closer to the biexponentialmodel, aswe observe. In addi-
tion, the actual size distribution of the hundreds of thousands of vacu-
oles present inside a relatively large voxel is likely less uniform than
predicted by the mathematical model. Thus, a key area for further
work is to study more sophisticated models, probably requiring more
exotic measurements (Drobnjak et al., 2010; Lasic et al., 2011) that in-
clude these effects. A better understanding of the hallmark MR features
will have an impact in designing new MR sequences and may improve
detection of disease in prionopathies, especially in pre-symptomatic
patients.
Another interesting question is the possibility to track progres-
sion of disease with the quantitative MR parameters considered in
this study. It has been recently outlined that ADC changes follow a
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time (Caverzasi et al., 2014) with respect to other neurodegenera-
tive diseases that follow a roughly linear or unidirectional decline.
The development of severe brain atrophy on MRI is associated
with the disappearance of the hyperintensity on DWI and ADC
“pseudo-normalization” in about 1–4% of CJD Caucasian patients
with a two-stage clinical course (so-called panencephalopathic
form). The initial rapid deterioration is followed by an unusually
prolonged state of akinetic mutism. We have examined one such pa-
tient with this same experimental diffusion protocol: in the severely
atrophic cortical regions that were previously hyperintense on DWI,
T2 values and diffusivities were increased while the restricted frac-
tion was decreased. These unique MRI results are in agreement
with the neuropathological ﬁndings at autopsy reporting complete
cortical cytoarchitecture collapse (status spongiosus), presence of
large gliotic scars and neuronal loss with disappearance of the
small vacuoles (Ghorayeb et al., 1998; Jansen et al., 2009).
The “pseudo-normalization” of ADC in patients with unusually
prolonged state of akinetic mutism is not related with the results
of this study in the regions with DWI hyperintensity, since we con-
sidered separately cortical regions with and without DWI signal
hyperintensity.
A few limitations of this study should be acknowledged. First of all,
we have a clinical diagnosis for all the patients but not autopsy-
proven results: so we could not look for a correlation of MR parameters
with neuropathological results. Regarding the acquisition protocol, the
twice-refocused SS-SE EPI DWI sequence available on our scanner has
advantages from the point of view of image quality, but does not
allow setting the diffusion time independently from the TE: a standard
Stejskal–Tanner sequence could help obtaining clearer results on the
dependence of the signal on the acquisition parameters. Moreover,
even though the ROIs were carefully drawn not to exceed GM the
2.3 mm isotropic spatial resolution used was in the range of cortical
thickness, therefore we cannot exclude some partial volume effects
with WM. Finally, more sophisticated models could be investigated, as
discussed above.
In conclusion, we thoroughly examined DWI data acquired with a
wide range of T2 and diffusionweightings and diffusion times in CJD pa-
tients. By comparing the raw MRI data of patients and healthy subjects
we investigated the dependence of the observed signal hyperintensity
on the acquisition parameters and we were able to suggest optimal
MRI parameters that may further highlight such hyperintensities in fu-
ture clinical studies. We showed that a biexponential or a spherical
restricted-diffusion model can ﬁt the data better than the generally
used mono-exponential model. In the affected ROIs we found that the
main contributions to DWI signal hyperintensity come from an increase
of T2 and some form of reduction of the diffusive motions, which is ex-
plained as a reduction of diffusivities by the mono- and biexponential
models and as an increase of the restricted compartment in the spheri-
cal restricted-diffusion model. Since the two bi-compartment models
performed similarly, we cannot conclude that either prion PrPSc deposi-
tion or spongiform degeneration is a more likely cause of DWI
hyperintensities. Both pathological changesmay contribute to the signal
abnormality or the degree of complexity of microstructural pathology is
higher than anticipated by the two models investigated in this study.
Future studies will have to test more sophisticated models, for example
accounting for vacuole permeability. For the ﬁrst time we were able to
show that it is feasible to estimate average vacuolar size with MRI. We
believe that this work represents an important step forward to a better
characterization of MRI abnormalities in prionopathies and to foster the
development of more sensitive sequences for early diagnosis of sCJD.
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Appendix A. Parameter constraints
Asmentioned in themain text, we started from amore general form
of the bi-compartment models, that is:
S ¼ M0½ f  e
− TET2;1  e−bd1 þ ð1− f Þe−
TE
T2;2  e−bd2  ðA1Þ
for the biexponential model and:
S ¼ M0 f  e−
TE





for the restricted-diffusion model.
The key difference between these equations and Eqs. (1) and (2) re-
spectively is that a different T2 is estimated in either compartment. We
performed some preliminary ﬁtting tests with thesemodels andwe no-
ticed a certain degree of instability in the results. Furthermore, the b=0
signal at various echo times showed no evidence of a biexponential
trend, so we decided to ﬁx the two T2 parameters to be equal in both
models.
An additional difference between the restricted-diffusion model in
Eq. (A2) and its ﬁnal form is that dR (the intrinsic diffusivity in the re-
stricted compartment) is a free parameter. However, from our prelimi-
nary tests we found that the results were insensitive to dR, so we
decided to ﬁx dR to a predetermined value; we chose the diffusivity of
free water at body temperature (3 × 10−9 m2/s) since vacuoles contain
mostly water.
Thus the models took the simpliﬁed form shown in Eqs. (1) and (2)
in the main text.
We also constrained the set ofmodel parameters in the optimization
using transformations that limit the range of each parameter to bio-
physically meaningful values. For all the models we constrained the T2
values and the diffusivities to be positive and the volume fractions to
be in [0, 1] and to sum to 1.
The reduction of the number of free parameters and the constraints
on the allowed values were aimed at and stabilizing the ﬁtting and pa-
rameter estimation.
Appendix B. Model ﬁtting
We ﬁtted each model to the data using an iterative non-linear opti-
mization procedure frommultiple starting points to avoid localminima.
Here we used a Levenberg–Marquardt algorithm (Marquardt, 1963) for
minimizing a chi-squared objective function with the Rician noise












where L is the likelihood of the measurements given the model esti-
mates,M is the number of measurements, σ is the standard deviation
of the noise, ~Sn is the nthmeasurement, Sn is themodel predicted signal
and I0 is the zero-order modiﬁed Bessel function of the ﬁrst kind. For all
models, we chose the best ﬁt parameters from themodels after 100 per-
turbations of the starting parameters to ensure a good minimum.
153M. Figini et al. / NeuroImage: Clinical 7 (2015) 142–154Measurements below a noise-ﬂoor threshold, chosen from the estimat-
ed noise viance, were ignored during the ﬁtting procedure.
The BIC (Schwarz, 1978) was calculated according to the following
formula:
BIC ¼−2logðLÞ þ k  logðMÞ ¼ 2F þ k  logðMÞ ðB2Þ
where L,M and F have the samemeaning as in Eq. (B1), while k is the
number of model parameters. It rewards the models that minimize the
objective function, but it simultaneously penalizes those with a high
number of parameters.
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